Effects of endothelin ET(A) receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits

European Journal of Pharmacology

Volumn 321, Issue 3, 1997, Pages 295-300

  Ignasiak, Diane P ^a   McClanahan, Thomas B ^a   Saganek, Lori J ^a   Potoczak, Ronald E ^a   Hallak, Hussein ^a   Gallagher, Kim P ^a  

^a PFIZER INC   (United States)

Author keywords

Endothelin ET(A) receptor antagonist; Endothelin 1; Renal; Vascular resistance

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; 1,3 DIOXOLANE DERIVATIVE; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SCREENING; HEART RATE; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TECHNIQUE; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY CIRCULATION; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; DIOXOLES; ENDOTHELIN-1; MALE; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 0030610292     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00954-5     Document Type: Article

References (21)

1. Benigni, A., C. Zoja, D. Corna, S. Orisio, L. Longaretti, T. Bertani and G. Remuzzi, 1993, A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression, Kidney Int. 44, 440.
2. Bigaud, M. and J.T. Pelton, 1992, Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala 1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat, Br. J. Pharmacol. 107, 912.
3. Clozel, M., G.A. Gray, V. Breu, B.M. Loffler and R. Osterwalder, 1992, The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo, Biochem. Biophys. Res. Commun. 186, 867.
4. Cornet, S., E. Pirotzky and P. Braquet, 1993, Implicaton of different endothelin receptors in the vascular action of a hypertensive dose of ET-1 in rat, J. Cardiovasc. Pharmacol. 22 (Suppl. 8), S239.
5. A) receptor selective antagonists, J. Med. Chem. 38, 1259.
6. Grover, G.J., S. Dzwonczyk and C.S. Parham, 1993, The endothelin-1 receptor antagonist BQ123 reduces infarct size in a canine model of coronary occlusion and reperfusion, Cardiovasc. Res. 27, 1613.
7. Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto and T. Masaki, 1989, The human endothelin family. Three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc. Natl. Acad. Sci. USA 86, 2863.
8. Kon, V., T. Yoshioda, A. Fogo and I. Ichikawa, 1989, Glomerular actions of endothelin in vivo, J. Clin. Invest. 83, 1762.
9. Koyama, H., T. Tabata, Y. Nishzawa, T. Inoue, H. Morii and T. Yamaji, 1989, Plasma endothelin levels in patients with uraemia, Lancet i, 991.
10. Kusumoto, K., Y. Aeane, S. Jujiwara and T. Watanabe, 1993, Role of endogenous endothelin in extension of rabbit myocardial infarction, J. Cardiovasc. Pharmacol. 22 (Suppl. 8), S339.
11. Lee, J.Y., R.B. Warner, A.L. Adler and T.J. Opgenorth, 1994, Endothelin-1 ET-A receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat, Pharmacology 49, 319.
12. Pernow, J., A. Franco-Cereceda, R. Matran and J.M. Lundberg, 1989, Effect of endothelin-1 on regional vascular resistances in the pig, J. Cardiovasc. Pharmacol. 13 (Suppl. 5), S205.
13. Rae, G.A., M. Trybulec, G. De Nucci and J.R. Vane, 1989, Endothelin-1 releases eicosaniods from rabbit isolated perfused kidney and spleen, J. Cardiovasc. Pharmacol. 13 (Suppl. 5), S89.
14. Reynolds, E.E., J.A. Keiser, S.J. Haleen, D.M. Walker, B. Olszewski, R.L. Schroeder, D.J. Taylor, O.K. Hwang, K.M. Welch, M.A. Flynn, D.M. Thompson, J.J. Edmunds, K.A. Berryman, M. Plummer, X. Cheng, W.C. Patt and A.M. Doherty, 1995a, Pharmacological characterization of PD156707, an orally active ETA receptor antagonist, J. Pharmacol. Exp. Ther. 273, 1410.
15. Reynolds, E.E., O.K. Hwang, M.A. Flynn, K.M. Welch, W.L. Cody, B. Steinbaugh, J.X. He, F. Chung and A.M. Doherty, 1995b, Pharmacological differences between rat and human endothelin B receptors, Biochem. Biophys. Res. Commun. 209, 506.
16. Rossi, D.T., H. Hallak and L. Bradford, 1996, Liquid chromatographic assay for a butenolide endothelin antagonist (PD 156707) in plasma, J. Chromatogr. B 677, 299.
17. Saito, Y., K. Nakao, M. Mukoyama and H. Imura, 1990, Increased plasma endothelin level in patients with essential hypertension, New Engl. J. Med. 322, 205.
18. Seo, B., B.S. Oemar, R. Siebenmann, L. Von Segesser and T.F. Luscher, 1994, Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels, Circulation 89, 1203.
19. Sumner, M.J., T.R. Cannon, J.W. Mundin, D.G. White and I.S. Watts IS, 1992, Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction, Br. J. Pharmacol. 107, 858.
20. Walder, C.E., G.R. Thomas, C. Thiemaermann and J.R. Vane, 1989, The hemodynamic effects of endothelin-1 in the pithed rat, J. Cardiovasc. Pharmacol. 13 (Suppl. 5), S93.
21. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto and T. Masaki, 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411.